HBV core region variability: effect of antiviral treatments on main epitopic regionsHOMS, Maria; JARDI, Rosendo; BUTI, Maria et al.Antiviral therapy (London). 2011, Vol 16, Num 1, pp 37-49, issn 1359-6535, 13 p.Article

Analysis of hepatitis B genotype changes in chronic hepatitis B infection : Influence of antiviral therapyJARDI, Rosendo; RODRIGUEZ-FRIAS, Francisco; SCHAPER, Melanie et al.Journal of hepatology. 2008, Vol 49, Num 5, pp 695-701, issn 0168-8278, 7 p.Article

A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a modelRAMIREZ, Clara; GREGORI, Josep; BUTI, Maria et al.Antiviral research. 2013, Vol 98, Num 2, pp 273-283, issn 0166-3542, 11 p.Article

Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and DSCHAPER, Melanie; RODRIGUEZ-FRIAS, Francisco; JARDI, Rosendo et al.Journal of hepatology. 2010, Vol 52, Num 5, pp 658-664, issn 0168-8278, 7 p.Article

Use of the Novel INNO-LiPA Line Probe Assay for Detection of Hepatitis B Virus Variants That Confer Resistance to Entecavir TherapyJARDI, Rosendo; RODRIGUEZ-FRIAS, Francisco; TABERNERO, David et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 2, pp 485-488, issn 0095-1137, 4 p.Article

Adefovir for chronic hepatitis B treatment : identification of virological markers linked to therapy responseRODRIGUEZ-FRIAS, Francisco; JARDI, Rosendo; SCHAPER, Melanie et al.Antiviral therapy (London). 2008, Vol 13, Num 8, pp 991-999, issn 1359-6535, 9 p.Article

Redetection of HBV lamivudine-resistant mutations in a patient under entecavir therapy, who had been treated sequentially with nucleos(T)ide analoguesRODRIGUEZ-FRIAS, Francisco; JARDI, Rosendo; SCHAPER, Melanie et al.Journal of medical virology. 2007, Vol 79, Num 11, pp 1671-1673, issn 0146-6615, 3 p.Article